Sign in
HOME
ABOUT
SUBSCRIBE
ADVERTISE
MEDICAL DEVICES
ACQUISITIONS/MERGERS
FDA UPDATES
FUNDING
OTHER NEWS
INDUSTRY EXPERT ARTICLES
EXECUTIVES
HOSPITALS
IMAGING
NON-PROFIT
MARKET REPORTS
ULTRASOUND
HEALTH
ARTICLES
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
PRIVACY STATEMENT MEDICAL DEVICE NEWS MAGAZINE
Password recovery
Recover your password
your email
Search
Monday, February 6, 2023
Facebook
Linkedin
Twitter
Medical Device News Magazine
A Digital Publication for the Practicing Medical Specialist, Industry Executive, and Investor
HOME
ABOUT
PRESS RELEASES
EDITORIAL
ADVERTISE
CONTACT
BIOTECHNOLOGY NEWS MAGAZINE
MEDICAL DEVICES
OTHER INDUSTRY NEWS
CLINICAL TRIALS
EXECUTIVES
FDA
FUNDING
INDUSTRY EXPERT ARTICLES
MERGERS / ACQUISITIONS
HOSPITALS
IMAGING
ROBOTICS
MARKET OUTLOOK
ULTRASOUND
NON-PROFIT
HEALTHCARE CAREERS
HEALTH
ARTICLES OF INTEREST
SUBSCRIBE TO OUR NEWSLETTER
Search
Search
Trending Now
Ernesto Pollano Promoted to General Sales Manager, Mexico / LATAM
Volta Medical Announces Completion of Patient Enrollment in TAILORED-AF Clinical Trial for Treatment of Atrial Fibrillation
SIS Medical AG announces the US-launch and the first US-treatment with the Super-High-Pressure balloon – OPN NC® – with TWIN-Wall technology
Intellihealth Launches Evolve Mobile 3.0
NeoDynamics Partners with Uniphar for US Distribution and Logistics
Search
Home
Tags
Penumbra
Penumbra
New Data Demonstrates Safety and Performance of Continuous Aspiration Thrombectomy with Indigo® System CAT™ RX Catheter in High-Risk Patients with Acute Coronary Syndrome
November 5, 2021
RED 62 Reperfusion Catheter Receives FDA Clearance & Now Commercially Available in the U.S.
June 23, 2021
INDIGO System Lightning 7 for Arterial Clot Removal Commercially Available In the U.S.
March 18, 2021
New Indigo System by Penumbra
July 14, 2020
HTC VIVE Technology Used in Penumbra’s REAL Immersive System for Stroke Patient Recovery
March 9, 2020
By using this website you agree to accept Medical Device News Magazine
Privacy Policy
Accept
Go to mobile version
